FDA Approved: ADCETRIS — Original Application (SEAGEN INC.)

View source ↗

Summary

FDA approved ADCETRIS (brentuximab vedotin) in its original application for CD30-expressing classical Hodgkin lymphoma and systemic anaplastic large cell lympho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Systemic Anaplastic Large Cell Lymphoma

Drugs mentioned

• Adcetris (Brentuximab vedotin)

Snippet

ORIG AP for ADCETRIS (BRENTUXIMAB VEDOTIN)